SHPH Shuttle Pharmaceuticals Holdings, Inc. - common stock
NASDAQ · Biotechnology · Ver em SEC EDGAR ↗ 10-K/10-Q Set 24, 2026
$4,86
· % da faixa de 52 semanas
· acima do mínimo
· para alta
$0,49mínima 52 sem
$6,15máxima 52 sem
Capitalização de Mercado (MRQ)
$5M
P/E
-0.1
EPS
$-7.16
seus distintivos
Intervalo 52 Semanas
$0–$6
Classificação do Analista
·
Preço-Alvo
·
P/E
-0.1
ROE
-400.1%
Margem de Lucro Líquido
·
Sua barra de distintivos está vazia — fixe uma métrica em qualquer lugar desta página.
SHPH Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
Preço
$4.86
Capitalização de Mercado (MRQ)
$5M
P/E
-0.1
EPS
$-7.16
ROE
-400.1%
Intervalo 52 Semanas
$0–$6
SHPH Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
intervalo
barras
A granularidade da barra se adapta ao período selecionado — passe o mouse sobre o gráfico para ver a abertura/máxima/mínima/fechamento de uma barra.
Divisões de Ações
| Data ex | Desdobramento | Tipo |
|---|---|---|
| 11 de Junho de 2026 | 1-for-10 | Reverso |
| 16 de Junho de 2025 | 1-for-25 | Reverso |
| 13 de Agosto de 2024 | 1-for-8 | Reverso |
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
EPS$-7.162022-12-31 → 2025-12-31
Fluxo de caixa livre·2023-12-31 → 2023-12-31
Margem líquida·2023-12-31 → 2024-12-31
Avaliação e Proporções
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
| Métrica | Tendência de 5 anos | SHPH | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| P/E | -0.1média 5A ≈-26.0 | ≈-26.0 | · | · | |
| P/B (MRQ) | 0.3média 5A ≈273.2 | ≈273.2 | 0.7 | Subvalorizado | |
| Price / Cash Flow (Preço / Fluxo de Caixa) | -0.1média 5A ≈-659.9 | ≈-659.9 | · | · | |
| Preço / Valor Patrimonial Tangível (MRQ) | 0.5média 5A ≈392.8 | ≈392.8 | · | · |
A mediana dos pares é calculada em uma base padronizada por métrica e pode não corresponder sempre à base TTM/MRQ mostrada para esta ação.
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
| Métrica | Tendência de 5 anos | SHPH | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| ROA | -180.6%média 5A ≈-154.0% | ≈-154.0% | -55.3% | Fraco | |
| ROE | -400.1%média 5A ≈859.7% | ≈859.7% | -128.2% | Fraco |
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
| Métrica | Tendência de 5 anos | SHPH | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Índice de liquidez corrente (MRQ) | 0.1média 5A ≈3.4 | ≈3.4 | 1.4 | Baixa liquidez | |
| Quick Ratio (Índice de Liquidez Seca) | 0.0média 5A ≈3.3 | ≈3.3 | 0.8 | Baixa liquidez |
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
| Métrica | Tendência de 5 anos | SHPH | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Revenue YoY (Receita Ano a Ano) | 0.00% | · | · | · |
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
Ainda não há dados para este grupo de rácios
Ainda não há dados fundamentais suficientes para calcular este grupo de proporções.
valor · ≈ média 5A · mediana do setor · veredicto relativo à mediana
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| R&D Expense | $4M | $4M | $4M | $1M | $1M | |
| SG&A Expense | $6M | $1M | $1M | $473.7K | $36.5K | |
| Operating Expenses | $12M | $8M | $6M | $2M | $2M | |
| Operating Income | $-12M | $-8M | $-6M | $-2M | $-2M | |
| Interest Income | $1.1K | $38.1K | $79.1K | · | · | |
| Other Non-op | $195.2K | $-1M | $-700.3K | $-3M | $590.9K | |
| Pretax Income | · | · | $-7M | $-5M | $-1M | |
| Net Income | $-12M | $-9M | $-7M | $-5M | $-1M | |
| EPS (Basic) | $-7.16 | $-79.65 | $-3.53 | $-5.04 | $-0.12 | |
| EPS (Diluted) | $-7.16 | $-82.60 | $-3.53 | $-5.04 | · | |
| Shares (Basic) | 1,637,926 | 114,807 | 1,866,275 | 1,337,742 | 9,301,750 | |
| Shares (Diluted) | 1,637,926 | 115,493 | 1,866,275 | 1,337,742 | · | |
| EBITDA | $-12M | $-8M | $-6M | $-3M | · |
Balanço Patrimonial
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $334.0K | $2M | $3M | $8M | $504.7K | |
| Short-term Investments | · | · | $3M | · | · | |
| Prepaid Expense | $168.9K | $290.8K | $114.5K | $161.1K | $4.9K | |
| Current Assets | $502.9K | $2M | $6M | $9M | $509.6K | |
| PP&E (Net) | $17.3K | $19.4K | $24.8K | $12.6K | $18.6K | |
| PP&E (Gross) | · | · | · | $127.5K | $127.5K | |
| Accum. Depreciation | · | · | $121.7K | $114.9K | $108.9K | |
| Intangibles | $10M | · | · | · | · | |
| Other Non-current Assets | · | · | · | $6.5K | · | |
| Total Assets | $10M | $3M | $6M | $9M | $651.6K | |
| Accounts Payable | $1M | $596.6K | · | · | · | |
| Short-term Debt | · | $190.3K | · | $685.5K | · | |
| Current Liabilities | $8M | $2M | $1M | $975.7K | $2M | |
| Capital Leases | $155.0K | $238.1K | $304.1K | · | $62.4K | |
| Total Liabilities | $8M | $2M | $2M | $975.7K | $2M | |
| Long-term Debt | · | · | · | · | $91.0K | |
| Common Stock | $2 | $2 | $20 | $17 | $93 | |
| Paid-in Capital | $49M | $35M | $29M | $27M | $12M | |
| Retained Earnings | $-46M | $-35M | $-25M | $-19M | $-14M | |
| Stockholders' Equity | $2M | $709.2K | $4M | $8M | $-2M | |
| Liabilities + Equity | $10M | $3M | $6M | $9M | $651.6K | |
| Shares Outstanding | 202,362 | 163,093 | 2,008,689 | 1,700,414 | 9,312,152 |
Fluxo de Caixa
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| D&A | $290.1K | $5.5K | · | · | · | |
| Stock-based Comp | $933.0K | $259.7K | $182.0K | $237.5K | $910.1K | |
| Amort. of Intangibles | $288.1K | · | · | · | · | |
| Operating Cash Flow | $-9M | $-7M | $-6M | $-3M | $-300.3K | |
| CapEx | · | · | $19.0K | · | · | |
| Investing Cash Flow | $-3M | $3M | $-3M | · | · | |
| Net Debt Issued | · | $-59.7K | · | · | · | |
| Stock Issued | · | $4M | · | $10M | · | |
| Net Stock Activity | · | $4M | · | $10M | · | |
| Financing Cash Flow | $11M | $4M | $3M | $11M | $687.9K | |
| Net Change in Cash | $-2M | $-656.3K | $-6M | $8M | $387.6K | |
| Free Cash Flow | · | · | $-6M | · | · |
Lucratividade
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Operating Margin | · | -7696.2% | -11148.2% | · | · | |
| Net Margin | · | -9144.8% | -12473.2% | · | · | |
| Pretax Margin | · | · | -12473.2% | · | · | |
| EBITDA Margin | · | -7696.2% | -11148.2% | · | · | |
| ROA | -180.6% | -216.2% | · | -65.1% | · | |
| ROE | -400.1% | 3017.0% | · | -37.7% | · |
Liquidez e Solvência
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Current Ratio | 0.1 | 1.4 | · | 8.8 | · | |
| Quick Ratio | 0.0 | 1.3 | · | 8.6 | · |
Eficiência
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.0 | · | · | · |
Por Ação
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Book Value / Share | $1.11 | $0.17 | · | $0.56 | · | |
| Revenue / Share | · | $0.03 | $0.03 | · | · | |
| Cash Flow / Share | $-5.79 | $-2.54 | $-2.99 | · | · | |
| Cash / Share | $0.17 | $0.47 | · | $0.62 | · | |
| EPS (TTM) | $-7.16 | $-82.60 | $-3.53 | $-5.04 | · |
Taxas de Crescimento
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue YoY | · | 0.00% | · | · | · |
Avaliação (TTM)
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Net Income TTM | $-12M | $-9M | $-7M | $-5M | · | |
| Market Cap | $4M | $88M | · | $5.33B | · | |
| P/E | -0.3 | -0.3 | -25.8 | -77.8 | · | |
| P/B | 1.6 | 123.4 | · | 694.5 | · | |
| P / Tangible Book | · | 123.4 | 360.6 | 694.5 | · | |
| P / Cash Flow | -0.4 | -11.9 | · | -1967.4 | · | |
| Earnings Yield | -397.8% | -384.6% | -3.9% | -1.3% | · |
Demonstração de Resultados
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $55.7K | $267.2K | $511.9K | $943.5K | $1M | $2M | $986.4K | $1M | $645.7K | $586.1K | $710.5K | $1M | $839.7K | $921.8K | $-1.4K | $669.0K | |
| SG&A Expense | $2M | $1M | $2M | $886.1K | $2M | $596.9K | $429.1K | $329.0K | $310.0K | $324.6K | $316.7K | $265.6K | $209.3K | $255.4K | $369.0K | $81.9K | |
| Operating Expenses | $4M | $2M | $3M | $2M | $4M | $3M | $2M | $3M | $1M | $1M | $1M | $2M | $1M | $2M | $530.3K | $821.5K | |
| Operating Income | $-4M | $-2M | $-3M | $-2M | $-4M | $-3M | $-2M | $-3M | $-1M | $-1M | $-1M | $-2M | $-1M | $-2M | $-530.3K | $-821.5K | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | · | $623.5K | · | · | · | · | |
| Interest Income | $90 | $209 | $523 | $486 | $81 | · | $3 | $2.5K | $14.2K | $21.5K | $22.4K | $20.8K | $19.3K | $16.7K | · | · | |
| Other Non-op | $804.0K | $64.4K | $173.3K | $-80.4K | $203.9K | $-101.8K | $178.7K | $-732.5K | $-548.6K | $-346.2K | $-357.7K | $-193.6K | $-718.7K | $569.7K | $-2M | $-177.0K | |
| Pretax Income | · | · | · | · | · | · | · | · | · | · | · | $-2M | · | $-975.1K | $-3M | $-998.4K | |
| Net Income | $-3M | $-2M | $-3M | $-2M | $-4M | $-3M | $-2M | $-4M | $-2M | $-2M | $-2M | $-2M | $-2M | $-975.1K | $-3M | $-998.4K | |
| EPS (Basic) | $-3.10 | $-0.43 | $-2.52 | $-1.05 | $-32.91 | $-7.60 | $-14.87 | $-39.83 | $-24.12 | $-0.83 | $-0.82 | $-0.91 | $-1.23 | $-0.57 | $-4.81 | $-0.10 | |
| EPS (Diluted) | $-3.10 | $-0.43 | $-2.52 | $-1.05 | $-32.91 | $-7.60 | $-17.82 | $-39.83 | $-24.12 | $-0.83 | $-0.82 | $-0.91 | $-1.23 | $-0.57 | $-4.81 | $-0.10 | |
| Shares (Basic) | 1,015,181 | 5,031,569 | · | 2,233,650 | 112,611 | 401,957 | · | 95,004 | 84,197 | 2,075,745 | · | 1,969,904 | 1,780,171 | 1,704,517 | · | 10,164,979 | |
| Shares (Diluted) | 1,015,181 | 5,031,569 | · | 2,233,650 | 112,611 | 401,957 | · | 95,004 | 84,197 | 2,075,745 | · | 1,969,904 | 1,780,171 | 1,704,517 | · | · | |
| EBITDA | $-4M | $-2M | · | $-2M | $-4M | $-3M | · | $-3M | $-1M | $-1M | · | $-2M | $-1M | $-2M | · | $-821.5K |
Balanço Patrimonial
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $90.2K | $1M | $334.0K | $2M | $5M | $5M | $2M | $156.7K | $695.6K | $1M | $3M | $4M | $5M | $7M | $8M | $9M | |
| Short-term Investments | · | · | · | · | · | · | · | · | $2M | $3M | $3M | $3M | $3M | $3M | · | · | |
| Receivables | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $6.0K | |
| Prepaid Expense | $306.1K | $1M | $168.9K | $1M | $374.2K | $446.8K | $290.8K | $103.0K | $139.5K | $129.6K | $114.5K | $170.1K | $78.9K | $203.8K | $161.1K | $163.1K | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | $81.5K | · | $6.5K | $6.5K | · | · | · | |
| Current Assets | $396.4K | $2M | $502.9K | $3M | $5M | $5M | $2M | $361.4K | $2M | $4M | $6M | $7M | $8M | $10M | $9M | $9M | |
| PP&E (Net) | $15.2K | $16.3K | $17.3K | $18.3K | $19.3K | $18.4K | $19.4K | $21.2K | $22.0K | $22.9K | $24.8K | $26.8K | $9.6K | $11.1K | $12.6K | $14.1K | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | · | · | · | $127.5K | · | $127.5K | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | · | · | · | $116.4K | $114.9K | $113.4K | |
| Intangibles | $9M | $9M | $10M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $6.5K | · | |
| Total Assets | $23M | $12M | $10M | $4M | $6M | $5M | $3M | $673.6K | $3M | $5M | $6M | $7M | $9M | $10M | $9M | $9M | |
| Accounts Payable | $3M | $2M | $1M | $1M | $1M | $896.9K | $596.6K | · | · | · | · | · | · | · | · | · | |
| Short-term Debt | · | · | · | · | · | · | $190.3K | · | · | · | · | · | · | $139.2K | · | · | |
| Current Liabilities | $3M | $8M | $8M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $810.4K | $493.7K | $1M | $975.7K | $970.5K | |
| Capital Leases | $112.3K | $134.1K | $155.0K | $175.3K | $195.2K | $220.1K | $238.1K | $255.6K | $267.0K | $288.6K | $304.1K | $308.4K | $329.8K | $751.7K | · | $6.7K | |
| Total Liabilities | $4M | $8M | $8M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $4M | $975.7K | $977.1K | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | $139.2K | · | · | |
| Common Stock | $9 | $57 | $20 | $13 | $11 | $63 | $2 | $29 | $21 | $21 | $20 | $160 | $155 | $137 | $17 | $136 | |
| Paid-in Capital | $71M | $52M | $49M | $45M | $45M | $41M | $35M | $32M | $30M | $30M | $29M | $19M | $19M | $17M | $27M | · | |
| Retained Earnings | $-52M | $-48M | $-46M | $-44M | $-41M | $-38M | $-35M | $-33M | $-29M | $-27M | $-25M | $-14M | $-12M | $-10M | $-19M | $-8M | |
| Stockholders' Equity | $19M | $3M | $2M | $1M | $4M | $3M | $709.2K | $-1M | $801.4K | $3M | $4M | $6M | $7M | $7M | $8M | $8M | |
| Liabilities + Equity | $23M | $12M | $10M | $4M | $6M | $5M | $3M | $673.6K | $3M | $5M | $6M | $7M | $9M | $10M | $9M | $9M | |
| Shares Outstanding | 1,001,165 | 5,551,290 | 2,023,615 | 1,235,507 | 1,070,773 | 6,382,694 | 163,093 | 2,946,099 | 2,106,233 | 2,102,511 | 2,008,689 | 15,999,125 | 15,482,038 | 13,654,127 | 1,700,414 | 13,586,393 |
Fluxo de Caixa
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $633.5K | $633.3K | · | · | $-979 | $1.0K | · | · | · | · | · | · | · | · | · | · | |
| Stock-based Comp | $-7.5K | $35.0K | $214.8K | $134.3K | $46.9K | $537.0K | $31.9K | $45.3K | $71.2K | $111.4K | $86.5K | $37.6K | $49.5K | $8.3K | $-119.2K | $23.7K | |
| Amort. of Intangibles | $632.3K | $632.3K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-567.6K | $-2M | $-973.0K | $-3M | $-3M | $-3M | $-3M | $-2M | $-1M | $-1M | $-1M | $-2M | $-2M | $-1M | $-635.8K | $-1M | |
| CapEx | · | · | · | · | · | · | · | · | · | · | $0 | · | · | · | · | · | |
| Investing Cash Flow | $-5M | $-36.0K | · | · | · | · | $0 | $2M | $1M | $101.3K | $87.0K | $-25.9K | $62.8K | $-3M | · | · | |
| Debt Issued | · | · | · | · | · | · | · | · | · | $600.0K | · | · | · | · | · | · | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | $600.0K | · | · | · | · | · | · | |
| Stock Issued | $0 | $3M | · | $0 | $0 | · | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $3M | · | · | · | $5M | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $5M | $3M | $2M | $-96.4K | $4M | $5M | $4M | $-196.8K | $-461.7K | $-40.0K | $-334.4K | $0 | $-139.2K | $3M | $-67.4K | $10M | |
| Net Change in Cash | $-999.7K | $755.9K | $-2M | $-3M | $305.1K | $3M | $2M | $-538.9K | $-703.0K | $-1M | $-1M | $-2M | $-2M | $-1M | $-703.2K | $9M |
Lucratividade
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | · | -10144.7% | · | · | · | -11985.3% | · | · | |
| Net Margin | · | · | · | · | · | · | · | · | · | · | · | · | · | -7565.3% | · | · | |
| Pretax Margin | · | · | · | · | · | · | · | · | · | · | · | · | · | -7565.3% | · | · | |
| EBITDA Margin | · | · | · | · | · | · | · | · | · | -10144.7% | · | · | · | -11985.3% | · | · | |
| ROA | -22.2% | -25.1% | · | -111.3% | -89.1% | -60.7% | · | -94.0% | -34.9% | · | · | -21.4% | -49.4% | -18.7% | · | -21.3% | |
| ROE | -27.6% | -64.9% | · | -5958.8% | -168.2% | -101.0% | · | -176.2% | -52.5% | · | · | -25.6% | -63.0% | -28.2% | · | -23.8% |
Liquidez e Solvência
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.1 | 0.3 | · | 1.7 | 3.1 | 2.8 | · | 0.2 | 1.8 | 3.0 | · | 8.6 | 17.1 | 7.5 | · | 9.6 | |
| Quick Ratio | 0.0 | 0.1 | · | 1.1 | 2.8 | 2.5 | · | 0.1 | 1.7 | 2.8 | · | 8.4 | 16.9 | 7.3 | · | 9.4 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.0 | · | · |
Eficiência
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | · | · | 0.0 | · | · | · | 0.0 | · | · |
Por Ação
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $19.16 | $0.60 | · | $1.13 | $3.37 | $0.51 | · | $-0.45 | $0.38 | $1.31 | · | $0.35 | $0.45 | $0.51 | · | $0.62 | |
| Revenue / Share | · | · | · | · | · | · | · | · | · | $0.01 | · | · | · | · | · | · | |
| Cash Flow / Share | · | $-0.48 | · | · | · | $-0.25 | · | · | · | $-0.60 | · | · | · | · | · | · | |
| Cash / Share | $0.09 | $0.20 | · | $1.70 | $4.50 | $0.71 | · | $0.05 | $0.33 | $0.67 | · | $0.24 | $0.35 | $0.53 | · | $0.67 | |
| EPS (TTM) | $-7.10 | $-7.29 | · | $-29.76 | $-68.54 | $-89.37 | · | $-65.60 | $-26.68 | $-3.79 | · | $-7.52 | $-6.71 | $-5.54 | · | · |
Avaliação (TTM)
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-10M | $-11M | · | $-11M | $-12M | $-10M | · | $-9M | $-7M | $-7M | · | $-8M | $-7M | $-5M | · | $-3M | |
| Market Cap | $3M | $4M | · | $4M | $4M | $62M | · | $98M | $168M | $171M | · | $1.95B | $3.56B | $3.63B | · | $12.47B | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | · | · | $3.62B | · | · | |
| P/E | -0.5 | -0.1 | · | -0.1 | -0.1 | -0.1 | · | -0.5 | -3.0 | -21.4 | · | -16.2 | -34.3 | -48.0 | · | · | |
| P/B | 0.2 | 1.1 | · | 3.1 | 1.1 | 18.9 | · | -74.5 | 210.2 | 61.8 | · | 347.9 | 513.4 | 525.9 | · | 1483.9 | |
| P / Tangible Book | 0.3 | · | · | 3.1 | 1.1 | 18.9 | · | · | 210.2 | 61.8 | · | 347.9 | 513.4 | 525.9 | · | 1483.9 | |
| P / Cash Flow | · | -1.6 | · | · | · | -24.6 | · | · | · | -137.8 | · | · | · | -2714.5 | · | · | |
| Earnings Yield | -218.5% | -1073.6% | · | -838.3% | -1820.5% | -919.0% | · | -197.3% | -33.4% | -4.7% | · | -6.2% | -2.9% | -2.1% | · | · |
Período mais recente à esquerda · valores nulos mostrados como ·
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Margem Operacional % | · | -7696.2% | -11148.2% | · | · |
| Lucro líquido | $-12M | $-9M | $-7M | $-5M | $-1M |
| EPS Diluído | $-7.16 | $-82.60 | $-3.53 | $-5.04 | · |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Índice de liquidez corrente | 0.1 | 1.4 | · | 8.8 | · |
| Índice de Liquidez Seca | 0.0 | 1.3 | · | 8.6 | · |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fluxo de caixa livre | · | · | $-6M | · | · |
Investidores institucionais (13F)
Atividade institucional — Q1 2026 vs trimestre anterior
| Novas posições | Posições encerradas | Aumentou | Diminuído | Variação líquida de ações |
|---|---|---|---|---|
| 2 (-2 vs trimestre anterior) | 3 (+2 vs trimestre anterior) | 2 (0 vs trimestre anterior) | 1 (0 vs trimestre anterior) | +42K |
Comparado a Q4 2025. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.
Executivos da empresa 15 insiders · 6 diretores · 8 conselheiros
| Investidor com informação privilegiada | Função | Última atividade | Ações detidas | Compras 12m | Vendas 12m | Líquido 12m |
|---|---|---|---|---|---|---|
| Anatoly Dritschilo | CEO and Chairman | 14 de Agosto de 2023 G | 2.100.000 | 0 | 0 | $0 |
| Timothy J. Lorber | Chief Financial Officer | 8 de Agosto de 2025 A | · | 0 | 0 | $0 |
| Hoek Michael Vander | Chief Financial Officer | 8 de Março de 2024 A | 103.852 | 0 | 0 | $0 |
| Peter Dritschilo | President and COO | 29 de Dezembro de 2022 S | 6.560 | 0 | 0 | $0 |
| Mira Jung | Chief Scientific Officer | 1 de Maio de 2024 A | 135.715 | 0 | 0 | $0 |
| Tyvin Rich | Chief Medical Officer | 29 de Dezembro de 2022 S | 2.429 | 0 | 0 | $0 |
| Joseph Tung | Conselheiro | 8 de Agosto de 2025 A | · | 0 | 0 | $0 |
| Oleh Nabyt | Conselheiro | 8 de Agosto de 2025 A | · | 0 | 0 | $0 |
| George Scorsis | Conselheiro | 8 de Agosto de 2025 A | · | 0 | 0 | $0 |
| Steven M Richards | Conselheiro | 8 de Agosto de 2025 A | 1.707 | 0 | 0 | $0 |
| Bette Jacobs | Conselheiro | 13 de Dezembro de 2023 S | 27.064 | 0 | 0 | $0 |
| Milton Brown | Conselheiro | 13 de Dezembro de 2023 S | 1.094.610 | 0 | 0 | $0 |
| Chris Senanayake | Conselheiro | 29 de Dezembro de 2022 S | 2.791 | 0 | 0 | $0 |
| HRT FINANCIAL LP | Detentor de 10% | 14 de Julho de 2026 S | 0 | 6 | 5 | $-323.066 |
| William Adkins | · | 2 de Setembro de 2022 J | 184.071 | 0 | 0 | $0 |
Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto
Comparação de pares (subindústria GICS) Métricas chave vs pares do setor
Base do ano fiscal, preços no fechamento do último ano fiscal de cada empresa.
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
Escolha as métricas que importam para si — clique no + ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.
Fonte: SEC 10-Q arquivado Set 24, 2026